---
layout: post
title: "Compounding Certain Beta-Lactam Products in Shortage Under Section 503A of the Federal Food, Drug, and Cosmetic Act; Guidance for Industry; Availability"
date: 2026-02-05 19:01:39 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-25622
original_published: 2022-11-23 00:00:00 +0000
significance: 8.00
---

# Compounding Certain Beta-Lactam Products in Shortage Under Section 503A of the Federal Food, Drug, and Cosmetic Act; Guidance for Industry; Availability

**Published:** February 05, 2026 19:01 UTC
**Source:** Federal Register
**Original Published:** November 23, 2022 00:00 UTC
**Document Number:** 2022-25622

## Summary

The Food and Drug Administration (FDA, Agency, or we) is announcing the availability of a final guidance for industry entitled "Compounding Certain Beta-Lactam Products in Shortage Under Section 503A of the Federal Food, Drug, and Cosmetic Act." This guidance describes FDA's regulatory and enforcement priorities regarding preparation of beta-lactam oral antibiotic suspension products that appear on FDA's drug shortage list by a licensed pharmacist in a State- licensed pharmacy or Federal facility.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/11/23/2022-25622/compounding-certain-beta-lactam-products-in-shortage-under-section-503a-of-the-federal-food-drug-and)
- API: https://www.federalregister.gov/api/v1/documents/2022-25622

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
